10 funding opportunities found in this category. Change the order of results: Newest First Oldest First Expiring Soonest Expiring Latest Lowest Award to Highest Highest Award to Lowest
Rosalinde Gilbert Innovations in Alzheimer’s Disease Caregiving Legacy Awards
With continuing support from The Rosalinde and Arthur Gilbert Foundation, Family Caregiver Alliance (FCA) is pleased to oversee the annual Rosalinde Gilbert Innovations in Alzheimer's Disease Caregiving Legacy Awards program in its sixth year.
Three awards of $20,000 each will be awarded to nonprofit organizations, government agencies or universities responding to a community need with a program or project which focuses primarily on family/informal caregivers of adults with Alzheimer's disease and related dementias. Only agencies operating within the continental United States are eligible to apply. One award will be granted in each of these categories:
Creative Expression: This award will go to programs or projects that use imaginative and creative approaches in supporting persons with dementia or family/informal caregivers of persons with Alzheimer's disease and related dementias. Some examples are programs or projects using art, music, theatre, journaling, multimedia (e.g. film, documentary, radio) or other types of creative expression.
Diverse/Multicultural Communities: This award will go to programs or projects that provide services, support or other types of outreach to family/informal caregivers of persons with Alzheimer's disease or related dementias in diverse ethnic, age diversity, religion/spirituality, gender, rural, low income, and LGBT or other communities.
Policy and Advocacy: This award will go to programs or projects that advocate for systems change for the benefit of family/informal caregivers or care recipients with Alzheimer's disease or related dementias. These efforts could focus on legislation, executive or administrative changes, advocacy campaigns, or any other action to strengthen the public or private sector's recognition and support of family/informal caregivers.
Award Timeline
Applications are available, online only. The closing deadline for 2013 applications is 5 p.m. (Pacific Time), Friday, August 16, 2013. Award announcements will be made by late November 2013. Award recipients will be honored at the 2014 Annual Conference of the American Society on Aging (ASA). Participates will be invited to present information about their awarded program or project at the conference. Travel stipends will be available for the conference.
Eligibility and Submission Conditions
Nonprofit organizations, government agencies and universities responding to a community need with a program or project that focuses primarily on family/ informal caregivers of adults with Alzheimer's disease and related dementias are eligible to apply. Family or informal caregivers are unpaid caregivers. The term includes family members, friends, domestic partners and neighbors. Support for family/informal caregivers need not be the primary mission of the organization, agency or university.
Nonprofit applicants must submit proof of their 501(c) (3) status or other nonprofit status by attaching a copy of their nonprofit designation letter to their application. For-profit entities are not eligible to apply.
The nominated program or project has to have been active during the calendar year of 2012 and/or 2013. If the program or project involves a major culminating event, that event must have occurred prior to application deadline.
For the Policy & Advocacy and Creative Expression categories, program or project may be related to either family/informal caregivers or persons with dementia or both.
For the Diversity/Multicultural Communities category, program/project must be specific to family/informal caregivers of persons with Alzheimer's disease or related dementias.
The applicant or other designated program or project representatives must be willing to share information about their program with others, including a presentation at a national professional conference, and to write up additional information to appear on FCA's website and/or future publications. Award recipients may also be asked to provide information about how the award was used to further advance the mission of the organization, agency, or university.
Application must be received by the extended deadline of 5 p.m. (Pacific Time), on Friday, August 16, 2013.
Applicants must apply electronically using the designated online system.
Applicants must designate the category in which they would like to be considered. Applicants are competing only against others within their chosen category. If the judges feel that the applicant would be better suited for another category, they will contact the applicant directly.
Request for Application: Cutaneous Lymphoma Foundation’s CLARIONS Research Awards Program
The signature funding initiative of the Research Awards Program (RAP), is the CLARIONS Grant Program, which stands for Curing Cutaneous Lymphoma by Advancing Research, Innovation and Offering New Solutions. This research grant program supports investigators interested in conducting innovative cutaneous lymphoma research. These grants will help uncover causes and improve the treatment and quality of life for patients. Discovering new avenues for better therapies and, one day, a cure for cutaneous lymphoma are key goals of this program.
Research Funding Priorities
Eligibility and Requirements
Investigators at all levels, from clinical and post-doctoral fellows to established investigators, are eligible to receive awards. Medical students and graduate students are not eligible. Non-U.S. investigators are eligible and the research funded by the RAP can be conducted at non-U.S. institutions. Investigators must be members of an established and recognized academic institution. All research projects involving human subjects must receive IRB approval.
Award Amounts
Each year the CLF will provide two $25,000 awards, renewable for 1 year contingent upon approval by the CLF Board of Directors based upon the CLF Scientific Review Board’s review and recommendation.
A small indirect cost amount between $1,000-$2,000 is allowable.
The CLF’s RAP seeks to fund innovative research in all areas of cutaneous lymphomas with particular interest in:
-- Etiology and risk factors of cutaneous lymphomas.
-- Measures of disease impact on individuals and populations affected by cutaneous lymphomas.
-- Translating discoveries into diagnostic and therapeutic advances in cutaneous lymphomas.
-- Optimizing therapies for cutaneous lymphomas.
-- Improving quality of life for individuals with cutaneous lymphomas
2013 Calendar of Award Events
January 31 - Public announcement of Request for Application (RFA)
July 31 - Application deadline
August - October - Scientific Review Board review
November - Recipients notified of award
December - Grant awards announced at ASH meeting
January, 2014 - Disbursement of Award and beginning of new award cycle
Cutaneous Lymphoma Foundation PO Box 374 Birmingham, MI 48012-0374
Telephone: 248-644-9014
Fax: 248-644-9014
American College of Cardiology Foundation/Merck Research Fellowships in Cardiovascular Disease
Four one-year fellowships will be awarded to support research in adult cardiology. Preference is given to individuals who have had no more than two years of prior full-time experience either in clinical or basic research. Recipients will be expected to pursue a full-time project in clinical research during their year of supported training.
Research Focus: In selecting applications, proposals addressing CVD and Cardiometabolic disorders are encouraged. Included are proposals that address pathophysiology, molecular genetics, metabolic abnormalities leading to cardiovascular disease, hypertension, heart failure, hyperlipidemia, inflammatory mechanisms and new pathways for drug discovery. Proposals focusing on clinically relevant outcomes as a result of the metabolic syndrome, diabetes or obesity are also encouraged. Outcomes studies should focus on clinical/and or systems of care (e.g., quality improvement) interventions, and use outcomes measures of importance to both patients and society, including mortality, significant morbidity or quality of life changes, or economic effects.
Preference for one award will be given to applicants focusing on disparities of care. Despite increased attention to health disparities at the national, state and community levels, relatively little progress has been made in achieving the vision of eliminating racial and ethnic health disparities. Since the rates of cardiovascular mortality in the United States are significantly higher for these patients and this is, in fact, the leading cause of death in this demographic, innovative approaches to eliminating these disparities are critical. In an effort to encourage and support research in this area, proposals will be encouraged that focus on gender, race, geographic, and economic inequalities in cardiovascular care.
Eligibility: Anyone currently in an adult cardiology fellowship training program recognized by the Accreditation Council for Graduate Medical Education or the American Osteopathic Association and who has the recommendation and agreement of his/her training program director and institution.
Selection: Judging will be by the ACCF/Research Fellowship Awards Committee. Criteria for selection will include:
• Scientific quality of the project;
• Relevance to the research focus as described above;
• Qualifications and commitment of the applicant; and
• The quality of the training environment.
Successful applicants may pursue this protected year of research either within or following their three years of required training. Preference will be given to individuals who:
• Will pursue clinical research training and experience directly involving patients or human subjects.
• Have had no more than two years of prior full-time research experience either in clinical or basic research.
• Will not hold another major external fellowship or salary award, (e.g., from the National Institutes of Health or the American Heart Association) during the ACCF/Merck funded year.
The Award: Four fellowships in the amount of $70,000 each, to be used for salary support, for one year of research to begin July 1, 2014 and run through June 30, 2015.
Funding Source: The ACCF is grateful to the Merck Company Foundation for their continued financial support for these awards.
Deadline: September 23, 2013
For more information: Email Julia Berman or call 800-253-4636, ext. 6648.
Call for Applications: HERA Women’s Cancer Foundation Community Grants Program
HERA provides support for local ovarian cancer groups via program development and through the HERA Community Grants program.
Grants are available for ovarian cancer support and awareness programs.
The HERA Women’s Cancer Foundation is now accepting applications for its Community Grants Program.
Applications are due June 3, 2013.
These $1,000 grants will be awarded to 501(c)(3) organizations for programs that improve the quality-of-life for women with ovarian cancer or raise awareness about the disease in novel and unusual ways.
The grant application deadline is June 1st of each year. Organizations can receive support for up to 3 years in a row.
Interested grassroots and community organizations are encouraged to apply.
The HERA Women’s Cancer Foundation gives five seed grants annually of $1,000 to help organizations start programs or support existing programs.
How to apply:
Download the printable Community Grant Application from the HERA Women’s Cancer Foundation website
Applicants must be a 501(c)(3) charitable organization
There is one grant cycle and grant applications must be received by June 3.
Please include the cover page with your application. An electronic copy in a single PDF file can be emailed to: Meg Steitz, Executive Director: meg@herafoundation.org
Call for Applications: International Foundation for Functional Gastrointestinal Disorders Research Grant Program
The International Foundation for Functional Gastrointestinal Disorders (IFFGD) is seeking applications for research grants.
Grant awards of $40,000 in direct costs each are available to three (3) investigators for innovative research related to idiopathic gastroparesis.
Basis
We are seeking proposals for research in humans that will ultimately lead to improvements in the understanding of idiopathic gastroparesis, its pathophysiology, and the care of patients.
The mission of IFFGD is patient-oriented. Our goal is to fund high-quality research. A preference will be given to clinical research, as well as basic research that is translational in nature.
Eligibility
Applicants must have completed an MD, PhD, or equivalent degree. Successful applicants must agree to acknowledge IFFGD support in any publications that result from the research, and to submit a final report to IFFGD within 18 months of initial receipt of funding (NIH form PHS 2590 or equivalent format).
Review Process
A Selection Committee, independent of IFFGD staff, will review applications and designate the grants. In evaluating the merits of an application, the Selection Committee will consider its scientific merit, its significance to the field, and its feasibility (including availability of adequate resources, personnel and facilities).
Program emphasis will include, but not be limited to, issues relating to:
symptom management
integrative physiological processes
therapeutic targets
new technology to help explain gastric function and relationship to human disease
neurobiology
quality of life
patient-physician relationships that improve outcomes and satisfaction with treatment
multi-disciplinary approaches, and
novel approaches to patient care.
Allowable Budget Expenses
Only direct costs are allowed. Indirect costs are not allowed in these grants. Within direct costs, there are no unallowable expenses.
Application Process
The deadline for submitting applications is midnight, Monday September 3, 2013.
The application must be sent either via email to IFFGD at awards@iffgd.org or uploaded via our online submission form here. An original signed face page will be required prior to award disbursement, but is not required to be sent with the application submission.
The awards will be announced December 15, 2013 and the award period will begin January 1, 2014. Grants are in pre-tax U.S. dollars.
Direct questions as follows:
Via email about the grants or online submission instructions – Susan Schneck at sschneck@iffgd.org
By phone at 1-414-964-1799.
Hospice and Palliative Nurses Foundation and Project on Death in America Nursing Leadership Award in Palliative Care
The Hospice and Palliative Nurses Foundation, in accordance with a grant from the Project on Death in America, selects a nurse from nominated candidates who has emerged as a leader in palliative care and whose work has improved nursing care for dying patients and their families.
The focus of the Nursing Leadership Award in Palliative Care is to transform our society’s medical culture and give priority to education, training, and clinical service in end-of-life care issues. By publicizing the activities and efforts of nursing leaders, and their impact on improving end-of-life care, the Hospice and Palliative Nurses Foundation furthers the mission of Project on Death in America to understand and transform the culture and experience of dying and bereavement.
The award is competitive and one winner is selected from the nomination pool, by the HPNF PDIA Nursing Leadership Award Review Committee, consisting of HPNF Board members and HPNA members. The awardee is recognized at the American Academy of Hospice and Palliative Medicine/Hospice and Palliative Nurses Association Annual Assembly. The award includes a $750 cash prize and travel-related expenses to attend the Annual Assembly. The award recipient is encouraged to submit an article for publication in a future issue of the Journal of Hospice and Palliative Nursing.
To be eligible for the award, nominees must:
· be a current HPNA Member
· work in the field of hospice and/or palliative nursing care with his/her compassionate, skilled work and end-of-life care implemented in the healthcare system
· be viewed as someone who promotes and supports improving end-of-life care
· be seen as a leader in the field of hospice and/or palliative care in his/her setting especially in the relief of pain
· promote a better understanding of the experiences of dying and bereavement
· empower caregivers to become agents of change within their own healthcare organization
· have implemented or effected one of the following:
o educational program
o training program
o research specific to hospice/palliative care
o model service delivery program
o national policy changes
o nomination materials must be received by HPNF on or before June 1
· The HPNF PDIA Nursing Leadership Award Review Committee takes into account adherence to submission guidelines, completeness of nomination materials and quality of responses when reviewing nominations
To apply:
· Deadline is strictly enforced
· Submit PDIA Nursing Leadership Award Nomination form and any required attachments to HPNF by e-mail at info@hpnf.org or by fax at 412-787-9305 on or before June 1.
Reeve Foundation Quality of Life Grants Program
The Reeve Foundation Quality of Life Grants Program awards grants to nonprofit organizations that provide services to individuals with paralysis.
Quality of Life grants, conceived by the late Dana Reeve, are awarded to programs or projects that improve the daily lives of people with paralysis, with some emphasis on but not limited to paralysis caused by spinal caused by spinal cord injuries. She started the Quality of Life grants program to recognize and support organizations that recognize and support organizations that help disabled individuals, their families and caregivers in ways that more immediately give them increased independence, day-to-day happiness, and improved access.
Funding is awarded twice yearly to nonprofit organizations that provide critical life-enhancing and life-changing programs and services that improve physical and emotional health. Funded projects offer a diversity of services and approaches: improving access; providing education and job training; sponsoring organized sporting opportunities; and more to individuals living with paralysis and their communities.
Quality of Life grants are funded through a cooperative agreement with the Centers for Disease Control and Prevention (Award #1U59DD000338-1).These grants are awarded to nonprofit organizations that address that needs of people living with paralysis caused by spinal cord and other injuries, diseases and birth conditions, including (but not limited to) stroke, spina bifida, multiple sclerosis, cerebral palsy and amyotrophic lateral sclerosis (ALS).
The Reeve Foundation gives special consideration to organizations that serve returning wounded military and their families, and to those that provide targeted services to diverse cultural communities.
Since 1999, the Reeve Foundation has provide 2,055 grants totalling over $15.7 million to organizations worldwide that help improve opportunities, access and quality of life for individuals living with paralysis, their families and their communities. This program recognizes the unique and numerous needs of these individuals and the importance of providing services and programs that enable them to participate in all areas of life.
Who Should Apply?
The Reeve Foundation supports, through Quality of Life grants, nonprofit organizations that serve individuals with physical disabilities, particularly paralysis, and their families. The Foundation aids larger organizations in representing and protecting the individuals with physical disabilities on a national level as well as local groups in having an immediate and practical impact on individual lives.
Quality of Life grants are most often awarded to nonprofit organizations that have IRS 501(c)(3) status, but may also be awarded to community parks, schools, veterans hospitals, tribal entities, etc. Most Quality of Life grants are awarded within the United States of America, although the Reeve Foundation does award a small number of grants to nonprofit organizations based outside the United States.
2013 Program Timeline
• 1st Cycle online application submission period opens January 2, 2013
• 1st Cycle application submission deadline: March 1, 2013 at 11:59 pm
• Decisions announced (and checks shipped) early June 2013
• 2nd Cycle online application submission period opens July 1, 2013
• 2nd Cycle application sumbission deadline September 3, 2013 at 11:59 pm
• Decisions announced (and checks shipped) early January 2014.
ALL APPLICANTS PLEASE NOTE: When crafting your application, please be mindful of the 2013 Program Timeline above to ensure that the proposed project correlates with the program funding schedule.
Should you have any questions, concerns or technical difficulties with the online application, please contact the Quality of Life department as soon as possible at QoL@ChristopherReeve.org, dvalente@ChristopherReeve.org, rsultzbaugh@ChristopherReeve.org or pmehta@ChristopherReeve.org or call 800-539-7309.
Multiple Sclerosis Foundation Computer Grant Program
Computer Grant Program provides refurbished desktop computers for individuals with MS on limited or fixed incomes. For those who do not know how to use a computer, training may be provided. The application process requires verification of a diagnosis of MS and a brief essay from the applicant explaining how a computer will enhance their quality of life. A computer, monitor, keyboard and mouse will be granted. Internet access and technical support will be the responsibility of the grant recipient. Applications are accepted from June 1 to September 1 of each year.
Multiple Sclerosis Foundation Brighter Tomorrow Grant
Each year the Multiple Sclerosis Foundation makes dreams come true for individuals with multiple sclerosis across the country through the Brighter Tomorrow grant.
The goal of the grant is provide individuals with MS with goods or services (valued at up to $1000.00 per recipient) to improve their quality of life by enhancing safety, self-sufficiency, comfort, or well-being.
Recipients of the Multiple Sclerosis Foundation's Brighter Tomorrow grant have received appliances, televisions, furniture, hobby supplies, retreats, and various home modifications.
To qualify, a person must be 18 years of age or older and diagnosed with MS, or the parent of a minor child diagnosed with MS, and be a permanent U.S. resident. They must not have any other means of fulfilling the need they express.
Applicants are asked to provide basic personal and financial information, and to write a brief essay of 100 words or less to describe how the grant would help them have A Brighter Tomorrow.
If you would like to apply for a Brighter Tomorrow grant, simply fill out our online application, print an application, or call 888-673-6287 to receive an application by mail. Applications are accepted from June 1 to September 1 of each year.
For further information on the Brighter Tomorrow grant, call our Program Services Department at 1-888-MSFOCUS or you can contact us by email: support@msfocus.org.
- Partially funded through a charitable donation from the Bayer Foundation.
Official Guidelines
Applications submitted must fulfill the following eligibility criteria to be considered for funding:
Applicant must be diagnosed with MS, or be the parent of a minor child with MS.
Applicant must be over the age of 18.
Applicant must have no existing financial net (such as Medicaid or private insurance) to cover the request.
Applicant must grant the MSF the right to use their name and photograph for promotional purposes.
Applicant must agree to sign a disclaimer.
Applicant must be a resident of the United States.
Application must be postmarked/ time-stamped between June 1 and September 1.
Request must be for specific goods or services.
Cash, medications, or items available through current programs are not included.
Applications are confidential and will be reviewed by the grant committee. Recipients will be notified in December.
International Rett Syndrome Foundation Basic Research Grant Program
IRSF announces the availability of Regular Research grants for international biomedical research to promote the understanding of MeCP2 in the pathogenesis of the neurobehavioral phenotype of Rett syndrome (RTT). We seek to gain a better understanding of the underlying pathology of the disorder leading to an amelioration of the symptoms and a cure for RTT. IRSF seeks to encourage research that encompasses innovative therapeutic approaches and state of the art diagnostic techniques.
IRSF encourages applications within the following emphasis areas:
Understanding the role of MeCP2 during normal brain development
Characterizing the role of MeCP2, including MeCP2 target genes, in normal structure and function of the developing and adult nervous system
Determination of the relationship between patterns of expression of MeCP2, FoxG1, CDKL5, and related proteins in the nervous system and the neurologic and behavioral phenotypes of patients with RTT and/or related animal models
The investigation of neuronal abnormalities that result from MeCP2 dysfunction
The role of microglial and macroglial cells in development as it relates to RTT
Understanding mechanisms and systems leading to aberrant behavior in RTT
The development of assistive technologies to improve the quality of life of individuals affected by RTT
Support for other advances in therapy such as physical therapy, communication and education
The two year Regular Research Grants are designed to assist investigators establish hypotheses relevant to Rett syndrome research and obtain future funding from other agencies. The maximum funding level for research grants is $100,000 over two years.
Frequency: Awards will be made in one cycle in 2013
Timeline: Letters of Intent due: July 1, 2013
Invitation of full applications by: July 19, 2013
Applications due: August 19, 2013
Please Note: IRSF requires all applicants to use our online submission process.
For application submission inquiries, please contact:
Janice Ascano, Ph.D. Manager of Grants and Research - jascano@rettsyndrome.org | 917-267-4504
For program related inquiries, please contact:
Steve Kaminsky, Ph.D., Chief Science Officer - skaminsky@rettsyndrome.org | 301-961-1559
1
